NEW YORK (GenomeWeb News) – NextBio today announced a deal with the Winship Cancer Institute of Emory University to identify biomarkers and treatments for multiple myeloma.

The organizations will collaborate on a translational study using NextBio Clinical to interpret molecular data from patients with the disease, which constitutes only about 1 percent of all cancers in the US but has been especially difficult to treat. The goal of the study will be to make new discoveries that can improve care given to patients with refractory and relapsed forms of myeloma, NextBio said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.